Fecal Bacterial Flora in Clostridium Difficile-Associated Diarrhea
NCT00304876 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5
Last updated 2010-09-10
Summary
The investigators propose to study intensively the bacteriology of feces in C. difficile associated diarrheal disease, using a variety of conventional and very up-to-date techniques.
Conditions
- Enterocolitis
- Pseudomembranous Colitis
- Antibiotic-Associated Colitis
Sponsors & Collaborators
-
Baylor College of Medicine
collaborator OTHER -
Michael E. DeBakey VA Medical Center
lead FED
Principal Investigators
-
Daniel M Musher, M.D. · Baylor College of Medicine, Houston VA Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-10-31
- Primary Completion
- 2007-01-31
- Completion
- 2007-01-31
Countries
- United States
Study Locations
More Related Trials
-
Fecal Microbiota Transplant by Oral Capsules With Lactobacilli for Recurrent Clostridium Difficile Infection
NCT03804736 ·Status: UNKNOWN ·Phase: NA
-
Fecal Microbial Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate Colitis
NCT03268213 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Addition of Lactobacillus to Metronidazole in Treatment of CDAD
NCT00304863 ·Status: WITHDRAWN ·Phase: PHASE4
-
Vancomycin vs. Nitazoxanide to Treat Recurrent C. Difficile Colitis
NCT00304889 ·Status: COMPLETED
-
Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics
NCT03117582 ·Status: COMPLETED
-
The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
NCT04675723 ·Status: COMPLETED
-
Fecal Microbiota Therapy for Recurrent Clostridium Difficile Colitis
NCT01973465 ·Status: UNKNOWN ·Phase: NA
-
Fecal Microbiota Transplantation for Primary Clostridium Difficile Diarrhea
NCT02801656 ·Status: WITHDRAWN ·Phase: PHASE3
-
Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridioides Difficile Infection
NCT03834038 ·Status: COMPLETED ·Phase: NA
-
Fecal Microbiota Transplantation for Early Clostridioides Difficile Infection
NCT04885946 ·Status: UNKNOWN ·Phase: NA
-
Fecal Transplant for Relapsing C. Difficile Infection
NCT01703494 ·Status: UNKNOWN ·Phase: PHASE2
-
Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection
NCT00304356 ·Status: COMPLETED ·Phase: PHASE3
-
Fecal Microbiota Transplantation in Recurrent or Refractory Clostridium Difficile Colitis
NCT01942447 ·Status: UNKNOWN ·Phase: NA
-
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
NCT02127398 ·Status: RECRUITING ·Phase: PHASE2
-
Probiotics Administration Via Colonoscopic Spray and Oral Administration in CDAD Patients
NCT05770726 ·Status: RECRUITING ·Phase: NA
-
Use of Recombinant Human Lactoferrin in Long-Term Care Patients With Feeding Tubes With Clostridium Difficile.
NCT00377078 ·Status: UNKNOWN ·Phase: NA
-
Lyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff Infection
NCT03353506 ·Status: COMPLETED ·Phase: PHASE2
-
Gut Microbiota Changes After Fecal Microbiota Transplantation
NCT02557685 ·Status: UNKNOWN ·Phase: PHASE2
-
Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection
NCT02326636 ·Status: COMPLETED
-
Pathogenic Mechanisms in C Diff Infection and Colitis
NCT01930032 ·Status: COMPLETED
-
Immune Response to C.Difficile Infection
NCT02797288 ·Status: UNKNOWN
-
Efficacy of 30-day Duration of Fidaxomicin for Recurrent C. Difficile Infection
NCT02395848 ·Status: TERMINATED ·Phase: PHASE3
-
Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection
NCT02743234 ·Status: COMPLETED ·Phase: PHASE3
-
Longitudinal Study of the Human Intestinal Microbiome
NCT00832286 ·Status: COMPLETED ·Phase: PHASE1
-
Fecal Microbiota Transplant (FMT) Plus Fidaxomicin for Severe or Fulminant Clostridium Difficile Infection
NCT03760484 ·Status: TERMINATED ·Phase: PHASE2